Capio's BA Occupational Health Are to be Discontinued
September 09, 2002 08:45 ET
|
Capio
GOTHENBURG, Sweden, Sept. 9, 2002 (PRIMEZONE) -- Effective October 1, Capio's Occupational Health business area is to be discontinued and the operating units transferred to other Capio Group business...
Pharmexa Buys the AutoVac TNF-Alpha Pharmaccine
September 09, 2002 06:36 ET
|
Pharmexa A/S
HOERSHOLM, Denmark, Sept. 9, 2002 (PRIMEZONE) -- Pharmexa has bought back the AutoVac(TM) TNF-alpha pharmaccine from Business Development Finance (Vaekstfonden).
In 1997, Pharmexa signed a license...
GenOdyssee Announces Positive Results of Proprietary Interferon-alpha Variants for the Treatment of Hepatitis C and Cancer; In Preclinical Disease Models Variants Demonstrate Increased Efficacy Compared to Those Currently Available on the Market
September 05, 2002 10:24 ET
|
GenOdyssee SA
PARIS, France, Sept. 5, 2002 (PRIMEZONE) -- GenOdyssee S.A., a biotherapeutics company specializing in discovering and developing drugs from functional genomics, today announced preclinical results...
Women First HealthCare to Present at Bear Stearns 15th Annual Healthcare Conference
September 05, 2002 07:01 ET
|
Women First HealthCare, Inc.
SAN DIEGO, Sept. 5, 2002 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) today announced that Edward F. Calesa, chairman, president and CEO, will be presenting at Bear Stearns 15th Annual...
TietoEnator Will Provide New Solutions for Improved Efficiency and Cooperation in Healthcare
September 05, 2002 04:34 ET
|
TietoEnator
ESPOO, Finland, Sept. 5, 2002 (PRIMEZONE) -- TietoEnator's comprehensive solution for primary and special health care, Effica, has been significantly expanded: it now includes, for example, SMS...
TietoEnator's Partnership Forum's Theme is the Future of the Welfare Society
September 05, 2002 04:30 ET
|
TietoEnator
ESPOO, Finland, Sept. 5, 2002 (PRIMEZONE) -- TietoEnator's Partnership Forum will gather nearly one thousand public administration and healthcare specialists from around Finland in Tampere Hall on...
Aventis Pharmaceuticals Makes Milestone Payment to Astex
September 04, 2002 03:20 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Sept. 4, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced that it has received the first milestone payment from Aventis...
Pyrosequencing Secures Access to Intellectual Property for Bacterial Identification
September 03, 2002 08:07 ET
|
Pyrosequencing
UPPSALA, Sweden, Sept. 3, 2002 (PRIMEZONE) -- Pyrosequencing AB (Stockholm:PYROA) today announced that the Company has secured access to important intellectual property covering the use of the RNase...
Gambro Establishes Separate Company to Capture Full Potential of Pathogen Reduction Technology
September 03, 2002 04:17 ET
|
Gambro
STOCKHOLM, Sweden, Sept. 3, 2002 (PRIMEZONE) -- Gambro AB (Stockholm:GAMBaST) (Stockholm:GAMBbST), a leading international medical technology and healthcare company, today announced that its wholly...
Tripep AB (publ): Interim Report for the Period January-June 2002
August 29, 2002 08:18 ET
|
Tripep
HUDDINGE, Sweden, Aug. 29, 2002 (PRIMEZONE) -- Tripep AB (publ):
-- Continued work on GPG and its metabolite has made it clear that
the company currently has no candidate drug in the HIV...